hepatoP Cancer Research Results
hepatoP, L,hepatoprotective: Click to Expand ⟱
| Source: |
| Type: |
Hepatoprotective is the ability of a chemical substance to prevent damage to the liver.
Grapefruit:
-hepatoprotective potential has emerged from the study of naringenin and naringin.
Blueberries/cranberries:
-proanthocyanidins
Grape:
Nopal (Cactus pear) and tuna (Cactus pear fruit) “Opuntia ficus-indica”:
Chamomile (Matricaria chamomilla or Chamomilla recutita):
Silymarin (Silybum marianum):
Blue green algae spirulina :
Propolis (bee glue):
POLYSACCHARIDES
β-glucans
|
BC, Breast Cancer: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
Nor, |
HUVECs |
|
|
|
toxicity↝, ChemoSen↑, selectivity↑, Apoptosis↑, necrosis↑, MMP↓, DNAdam↑, cl‑PARP↑, MRP1/ABCC1↓, Bcl-2↓, hepatoP↑, cardioP↑, BioAv↝,
*lipid-P↓, *MDA↓, *antiOx↑, *Inflam↑, RenoP↑, hepatoP↑, *ALAT↓, AST↓, creat↓, chemoPv↑, Cyt‑c↑, FADD↑, P53↑,
other↝, AntiTum↑, Dose↝, TumCG↓, ALAT↓, AST↓, hepatoP↑, COX2↓, MMP2↓, MMP9↓,
| - |
in-vitro, |
BC, |
4T1 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
cardioP↑, hepatoP↑, TumCG↓, OS↑, ChemoSen↑, chemoP↑, Hif1a↓, *Hif1a↑, selectivity↑, TumVol↓, OS↑,
| - |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
TumCP↓, tumCV↓, BAX↑, cl‑PARP↑, Casp9↑, p‑JNK↑, Bcl-2↓, p‑p38↓, p‑ERK↓, *toxicity∅, Dose↝, *hepatoP↑, Inflam↓, AntiCan↑,
| - |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
p‑p38↑, ROS↑, TumCP↓, eff↑, XIAP↓, survivin↓, Bcl-xL↓, Bcl-2↓, Ki-67↓, *Catalase↑, *SOD↑, *GSH↑, hepatoP↑, p‑MAPK↑, JNK↓, eff↓,
Showing Research Papers: 1 to 6 of 6
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 6
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
ROS↑, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
MMP↓, 1, XIAP↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
ALAT↓, 1,
Cell Death(tgid=5) ⓘ
Apoptosis↑, 1, BAX↑, 1, Bcl-2↓, 3, Bcl-xL↓, 1, Casp9↑, 1, Cyt‑c↑, 1, FADD↑, 1, JNK↓, 1, p‑JNK↑, 1, p‑MAPK↑, 1, necrosis↑, 1, p‑p38↓, 1, p‑p38↑, 1, survivin↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
other↝, 1, tumCV↓, 1,
DNA Damage & Repair(tgid=10) ⓘ
DNAdam↑, 1, P53↑, 1, cl‑PARP↑, 2,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
p‑ERK↓, 1, TumCG↓, 2,
Migration(tgid=13) ⓘ
Ki-67↓, 1, MMP2↓, 1, MMP9↓, 1, TumCP↓, 2,
Angiogenesis & Vasculature(tgid=14) ⓘ
Hif1a↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2↓, 1, Inflam↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↝, 1, ChemoSen↑, 2, Dose↝, 2, eff↓, 1, eff↑, 1, MRP1/ABCC1↓, 1, selectivity↑, 2,
Clinical Biomarkers(tgid=22) ⓘ
ALAT↓, 1, AST↓, 2, creat↓, 1, Ki-67↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 1, AntiTum↑, 1, cardioP↑, 2, chemoP↑, 1, chemoPv↑, 1, hepatoP↑, 5, OS↑, 2, RenoP↑, 1, toxicity↝, 1, TumVol↓, 1,
Total Targets: 53
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 1, Catalase↑, 1, GSH↑, 1, lipid-P↓, 1, MDA↓, 1, SOD↑, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
ALAT↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
Hif1a↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
Inflam↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
ALAT↓, 1,
Functional Outcomes(tgid=23) ⓘ
hepatoP↑, 1, toxicity∅, 1,
Total Targets: 12
Scientific Paper Hit Count for: hepatoP, L,hepatoprotective
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:4 Cells:% prod#:% Target#:1179 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page